Top 10 Questions to Ask Your Oncology Billing Vendor About Prior Authorizations
The financial health of an oncology practice hinges on the efficiency of its revenue cycle management (RCM), and no process is more critical—or more challenging—than prior authorization (PA). Delays or errors in obtaining PA for cancer treatments, high-cost drugs, and complex diagnostic imaging can lead to patient care delays, significant claim denials, and lost revenue.
When evaluating a medical billing vendor to handle your oncology billing, their expertise in managing PAs is non-negotiable. Asking the right questions upfront will help you vet their capabilities and ensure a smooth, compliant, and profitable billing operation.
Here are the 10 essential questions to ask your potential oncology billing partner about their prior authorization process:
Table of Contents
The 10 Essential Prior Authorization Questions
1. What is your average PA turnaround time for common oncology services (e.g., chemotherapy, radiation)?
Timeliness directly impacts patient care scheduling and your revenue cycle speed. A great vendor should have documented metrics that show their efficiency, especially for services requiring immediate authorization. Look for a commitment to submitting clean claims immediately upon successful PA.
2. What technology and automation tools do you use to track and manage PA requests?
Manually tracking authorizations is prone to error and delay. A top-tier vendor will utilize specialized RCM software and automation to check payer requirements instantly, monitor expiration dates, and flag urgent cases, ensuring a seamless and efficient workflow.
3. What is your initial PA denial rate, and how quickly do you initiate the appeals process?
While some denials are inevitable, a low initial denial rate (ideally under 5%) indicates deep expertise. More importantly, probe their denial management strategy. They should have a clear, rapid process for initiating the first-level appeal and escalating persistent issues.
4. How do you stay updated on continuously changing payer guidelines and specific local coverage determinations (LCDs)?
Oncology coding is complex, with rules constantly shifting, especially concerning novel therapies (biologics, immunotherapies). Your vendor must demonstrate a robust training and research system to stay current on all payer guidelines and medical necessity requirements.
5. Describe your process for handling 'retro-authorizations' when emergent care is provided.
Cancer care often involves urgent or emergent services (e.g., infusion for a sudden complication). The vendor must have specialized experience in successfully obtaining authorization after the service has been rendered, a notoriously difficult process, to prevent a hard write-off.
6. How do you verify the patient’s eligibility, benefits, and financial responsibility before requesting PA?
A comprehensive PA process starts with meticulous eligibility verification. Failing to confirm co-pays, deductibles, and benefits before the service can lead to unexpected bills for the patient and collections issues for the practice. Patient responsibility must be confirmed early.
7. How do you manage PA for clinical trials and investigational services?
Billing for services rendered within a clinical trial is a highly specialized area of oncology billing. The vendor must demonstrate a clear understanding of what is billable to the payer versus what falls under the research sponsor, including proper use of diagnosis codes and modifiers in Clinical Research Billing.
8. What is the specific training or certification your PA specialists hold regarding oncology?
General medical billing experience isn't enough. Your PA team should include specialists familiar with high-cost, high-scrutiny cancer treatment billing, including drugs, supportive care, and surgical oncology procedures. This ensures accurate oncology coding.
9. What customized reporting do you provide to demonstrate PA performance and identify problem payers?
Transparency is key. You need regular reports detailing authorization submission volume, approval rates by payer, denial trends, and the root cause of denied PAs. These performance metrics allow you to identify and address bottlenecks with specific insurance companies.
10. How do you handle PA for facility vs. professional components in hospital-based practices?
If your practice operates in a hospital setting, the vendor must clearly delineate their process for managing PAs for both the professional services (physician fees) and the facility services (hospital charges), which often require separate, but coordinated, authorizations for seamless Facility Billing.
Don't Let Prior Authorizations Cripple Your Revenue
Choosing an oncology billing vendor is one of the most important operational decisions your practice will make. A vendor with a robust, transparent, and successful PA process serves as a financial guardian, protecting your revenue stream while enabling timely, uninterrupted patient care.
If you are looking for a partner with proven expertise in complex oncology RCM and highly effective prior authorization management, learn more about our specialized oncology billing services today.
Top 5 Prior Authorization FAQs for Oncology Billing
• Initial PA Denial Rate
• Approval Success Rate by Payer
• Turnaround Time
These metrics allow for transparent performance review.
Request for Information
Our oncology billing experts can help you improve collections, lower denials, and strengthen appeals. Fill out the form below or connect with us today to get started.
